Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Article Published: August 2008 Targeted imaging of myocardial damage David E Sosnovik, Matthias Nahrendorf & Ralph Weissleder Nature Clinical Practice Cardiovascular Medicine 5, S63–S70 (2008 ...

Myocardial infarction (MI) is an uncommonly suspected cause of morbidity in children. This retrospective case series study was undertaken to ascertain the incidence and etiologies of MI in the ...